PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Low levels of a simple sugar -- A new biomarker for severe MS?

2021-05-12
(Press-News.org) Multiple sclerosis, or MS for short, manifests itself slightly differently in each person - which is why some call it "the disease of a thousand faces." Arguably the worst manifestation of MS is its chronic progressive form. Unlike the more common relapsing-remitting variant (RRMS), in which sufferers are often symptom-free for months or even years, patients with the primary progressive form of the disease (PPMS) see their condition steadily deteriorate with no remissions.

Poorly insulated neurons die off

Today's therapeutic approaches are based on the assumption that the immune system is making a mistake and waging an inappropriate attack on the layer of myelin that surrounds and insulates the nerve cells' long, cable-like branches called axons. "In progressive MS, neurodegenerative processes steadily multiply and cause more and more neurons in the brain and spinal cord to die," explains Dr. Alexander Brandt, lead author of the study that has now been published in the journal JAMA Neurology. "However, we still do not know what exactly causes this disease variant."

Together with Professor Friedemann Paul from the Experimental and Clinical Research Center (ECRC), a joint institution of Charité - Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), as well as eleven colleagues from Berlin, Irvine and Toronto, Brandt now hopes he has shed some more light on the subject. As the team reports in their study, it appears that the simple sugar N-acetylglucosamine, or GlcNAc for short, could play an important role in the development of progressive MS. Inside an organism, GlcNAc and other sugar molecules attach to proteins on the cell surface in the form of chains. This mechanism, which is known as glycosylation, controls various cell functions by forming branched structures from these sugar chains.

The sugar molecule could serve as a biomarker

"We studied 120 subjects from Irvine and were able to show that, in this particularly severe form of the disease, there are significantly lower concentrations of N-acetylglucosamine in the blood serum than there are in healthy people or patients with relapsing-remitting MS," reports Brandt. At the time of this study, the physician was head of the Translational Neuroimaging laboratory in Paul's Clinical Neuroimmunology group at Charité. Brandt has since moved to the School of Medicine at the University of California, Irvine (UCI) as an associate professor of neurology, but remains a guest researcher at Charité.

"In another study of 180 patients from Berlin with relapsing-remitting or progressive MS, we also found that low serum levels of GlcNAc are associated with the development of the progressive form of the disease, clinical disability and neurodegeneration," adds the study's corresponding author, Professor Michael Demetriou of UC Irvine. "This opens up potential new avenues for identifying, at an early stage, which patients are at higher risk of progressive MS and adjusting their treatment accordingly."

Human treatment studies now in the pipeline

Back in autumn 2020, Brandt, Demetriou and other researchers working with the then lead author Dr. Michael Sy from UC Irvine published a study in the Journal of Biological Chemistry. They had administered GlcNAc to lactating mice and found that the animals passed on this simple sugar, which incidentally is also contained in human breast milk, to their offspring. This stimulated primary myelination of the neuronal axons in the young animals. "We also observed in the mouse experiments that N-acetylglucosamine activates myelin progenitor cells, thus promoting both primary myelination and the repair of damaged myelin," says Brandt.

The researchers therefore hope that GlcNAc not only has potential as a suitable biomarker for progressive MS, but could also pave the way for new therapeutic strategies. "Our hope is that we can use GlcNAc and the associated glycosylation mechanism to promote myelin repair and thus reduce neurodegeneration," summarizes Brandt. An initial, as-yet-unpublished phase I trial has just been completed with around 30 subjects, where the scientists investigated the safety of taking GlcNAc in certain doses. If it is shown to be safe, the scientists hope to be able to conduct further studies into this simple sugar's possible efficacy as an MS therapy.

INFORMATION:

This study was funded in part by a grant from the National Institute of Allergy and Infectious Disease and the National Center for Complimentary and Integrative Health as well as the German Excellence Cluster NeuroCure.

- Joint press release of MDC and Charité - Universitätsmedizin Berlin -

Scientific contact

Dr. Alexander U. Brandt
Director, Translational Neuroimaging Laboratory
Clinical Neuroimmunology
Experimental and Clinical Research Center (ECRC)
Charité - Universitätsmedizin Berlin
alexander.brandt@charite.de

About the ECRC

As a joint institution of the MDC and Charité, the Experimental and Clinical Research Center facilitates and promotes collaborative research between basic scientists and clinical researchers. It is a place where new approaches are developed for diagnosis, prevention and therapy, and translated to patients as quickly as possible. The Clinical Neuroimmunology Lab led by Prof. Friedemann Paul investigates the underlying causes and potential therapies for autoimmune neuroinflammatory diseases such as multiple sclerosis.

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) is one of the world's leading biomedical research institutions. Max Delbrück, a Berlin native, was a Nobel laureate and one of the founders of molecular biology. At the MDC's locations in Berlin-Buch and Mitte, researchers from some 60 countries analyze the human system - investigating the biological foundations of life from its most elementary building blocks to systems-wide mechanisms. By understanding what regulates or disrupts the dynamic equilibrium in a cell, an organ, or the entire body, we can prevent diseases, diagnose them earlier, and stop their progression with tailored therapies. Patients should benefit as soon as possible from basic research discoveries. The MDC therefore supports spin-off creation and participates in collaborative networks. It works in close partnership with Charité - Universitätsmedizin Berlin in the jointly run Experimental and Clinical Research Center (ECRC), the Berlin Institute of Health (BIH) at Charité, and the German Center for Cardiovascular Research (DZHK). Founded in 1992, the MDC today employs 1,600 people and is funded 90 percent by the German federal government and 10 percent by the State of Berlin. http://www.mdc-berlin.de



ELSE PRESS RELEASES FROM THIS DATE:

Interactive typeface for digital text

2021-05-12
AdaptiFont has recently been presented at CHI, the leading Conference on Human Factors in Computing. Language is without doubt the most pervasive medium for exchanging knowledge between humans. However, spoken language or abstract text need to be made visible in order to be read, be it in print or on screen. How does the way a text looks affect its readability, that is, how it is being read, processed, and understood? A team at TU Darmstadt's Centre for Cognitive Science investigated this question at the intersection of perceptual science, cognitive ...

Giant sea lizard fossil shows diversity of life before asteroid hit

2021-05-12
A giant mosasaur from the end of the Cretaceous period in Morocco that could have reached up to eight metres long is the third new species to be described from the region in less than a year, bringing the total number of species up to at least 13. The high diversity of the fauna shows how mosasaurs, giant marine lizards related to snakes and Komodo dragons, thrived in the final million years of the Cretaceous period before they, and most of all species on Earth, were wiped out by the impact of a giant asteroid 66 million years ago. The new species, named Pluridens serpentis, had long, slender jaws with over a hundred sharp, ...

Efficiently smuggling drugs into cells

Efficiently smuggling drugs into cells
2021-05-12
Modern vaccines such as those against Sars-CoV-2 use tiny lipid spheres to transport genetic information into cells and let the body build up an immune defense against the virus. A team of scientists from Erlangen, Dresden, and London has now developed a completely new method to very efficiently deliver not only genes but also drugs and other substances into cells. The researchers from the Max-Planck-Zentrum für Physik und Medizin (MPZPM) in Erlangen, the Technical University of Dresden, and The Institute of Cancer Research in London have named the method Progressive Mechanoporation and have now published it in the scientific journal "Lab on a Chip". They have also filed a patent. Ruchi Goswami and Alena Uvizl were part of a team of scientists led by Salvatore Girardo (Erlangen) ...

An enzyme system for the hydrogen industry

An enzyme system for the hydrogen industry
2021-05-12
An enzyme could make a dream come true for the energy industry: It can efficiently produce hydrogen using electricity and can also generate electricity from hydrogen. The enzyme is protected by embedding it in a polymer. An international research team with significant participation of scientists from Technical University of Munich (TUM) has presented the system in the renowned science journal Nature Catalysis. Fuel cells turn hydrogen into electricity, while electrolysers use electricity to split water to produce hydrogen. Both need the rare and thus expensive precious metal platinum as a catalyst. Nature has created a different solution: Enzymes, referred to as hydrogenases. ...

Locomotion Vault will help guide innovations in virtual reality locomotion

2021-05-12
Experts in virtual reality locomotion have developed a new resource that analyses all the different possibilities of locomotion currently available. Moving around in a virtual reality world can be very different to walking or employing a vehicle in the real world and new approaches and techniques are continually being developed to meet the challenges of different applications. Called Locomotion Vault, the project was developed by researchers at the Universities of Birmingham, Copenhagen, and Microsoft Research. It aims to provide a central, freely-available ...

Xerocrassa montserratensis, an endemic and threatened snail in Catalonia

Xerocrassa montserratensis, an endemic and threatened snail in Catalonia
2021-05-12
A study published in the journal Scientific Reports reveals the genetic structure of the land snail Xerocrassa montserratensis and it provides new scientific tools for the improvement of the conservation of this endemic and threatened species in Catalonia. This land mollusc, identified in the late 19th century in the Montserrat mountain, has a reduced geographical distribution limited to the province of Barcelona, and it is a protected species in the area of the natural parks of Montserrat and Sant Llorenç del Munt i l'Obac. The study is led by the lecturer Marta Pascual, from the Faculty of Biology and the Biodiversity Research Institute of the University of Barcelona ...

20 days later -- The short story about muscles regeneration

20 days later -- The short story about muscles regeneration
2021-05-12
Skeletal muscles make a tremendous variety of actions stabilizing the body in different positions. Despite their endurance during daily activities, they can undergo several mild injuries caused by sport, accidental overstretching, or sudden overtwisting. Luckily mild injuries can be quickly healed; however, when a large part of muscles is damaged or resected surgically, the full recovery can be impossible. Muscle regeneration is challenging, but the development of innovative biocompatible materials tackles that problem. Recently, a multinational team of scientists led by dr. Marco Costantini from ...

Acta Pharmaceutica Sinica B Volume 11, Issue 4 publishes

Acta Pharmaceutica Sinica B Volume 11, Issue 4 publishes
2021-05-12
Acta Pharmaceutica Sinica B Volume 11, Issue 4 Publishes https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b/vol/11/issue/4 Special Issue: The Biological Fate of Drug Nanocarriers This special issue includes seven review and nine research articles from some leading scientists in the field that further the discussion on subtopics of in vivo fate of drug nanocarriers. Guest Editors: Wei Wu, Professor, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China; Tonglei Li, Professor, Department of Industrial & Physical Pharmacy, Purdue University, West Lafayette, IN, USA; Ying Zheng, Professor, State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China. The Journal ...

Violinmaking meets artificial intelligence

Violinmaking meets artificial intelligence
2021-05-12
How to predict the sound produced by a tonewood block once carved into the shape of a violin plate? What is the best shape for the best sound? Artificial Intelligence offer answers to these questions. These are the conclusions that researchers of the Musical Acoustics Lab of Politecnico di Milano presented in a study that was recently published in Scientific Reports. In the article "A Data-Driven Approach to Violinmaking" the Chilean physicist and luthier Sebastian Gonzalez (post-doc researcher) and the professional mandolin player Davide Salvi (PhD student) show how a simple and effective neural network is able to predict the vibrational be-havior of violin plates. This prediction is obtained from a limited set of geometric and mechanical ...

LAMOST helps Gaia achieve millimagnitude photometry precision

LAMOST helps Gaia achieve millimagnitude photometry precision
2021-05-12
The Large Sky Area Multi-Object Fiber Spectroscopic Telescope (LAMOST) has helped Gaia achieve millimagnitude (mmag) precision in photometry, according to a study led by researchers from National Astronomical Observatories of Chinese Academy of Sciences (NAOC) and Beijing Normal University (BNU). Their study was published in The Astrophysical Journal. If you look at the sky on a clear, starry night, you may notice that Aldebran is relatively red and Rigel is blue. Why? The answer stems from their intrinsic physical properties. Precisely measuring magnitudes ...

LAST 30 PRESS RELEASES:

AASM Foundation partners with Howard University Medical Alumni Association to provide scholarships

Protective actions need regulatory support to fully defend homeowners and coastal communities, study finds

On-chip light control of semiconductor optoelectronic devices using integrated metasurfaces

America’s political house can become less divided

A common antihistamine shows promise in treating liver complications of a rare disease complication

Trastuzumab emtansine improves long-term survival in HER2 breast cancer

Is eating more red meat bad for your brain?

How does Tourette syndrome differ by sex?

Red meat consumption increases risk of dementia and cognitive decline

Study reveals how sex and racial disparities in weight loss surgery have changed over 20 years

Ultrasound-directed microbubbles could boost immune response against tumours, new Concordia research suggests

In small preliminary study, fearful pet dogs exhibited significantly different microbiomes and metabolic molecules to non-fearful dogs, suggesting the gut-brain axis might be involved in fear behavior

Examination of Large Language Model "red-teaming" defines it as a non-malicious team-effort activity to seek LLMs' limits and identifies 35 different techniques used to test them

Most microplastics in French bottled and tap water are smaller than 20 µm - fine enough to pass into blood and organs, but below the EU-recommended detection limit

A tangled web: Fossil fuel energy, plastics, and agrichemicals discourse on X/Twitter

This fast and agile robotic insect could someday aid in mechanical pollination

Researchers identify novel immune cells that may worsen asthma

Conquest of Asia and Europe by snow leopards during the last Ice Ages uncovered

Researchers make comfortable materials that generate power when worn

Study finding Xenon gas could protect against Alzheimer’s disease leads to start of clinical trial

Protein protects biological nitrogen fixation from oxidative stress

Three-quarters of medical facilities in Mariupol sustained damage during Russia’s siege of 2022

Snow leopard fossils clarify evolutionary history of species

Machine learning outperforms traditional statistical methods in addressing missing data in electronic health records

AI–guided lung ultrasound by nonexperts

Prevalence of and inequities in poor mental health across 3 US surveys

Association between surgeon stress and major surgical complications

How cryogenic microscopy could help strengthen food security

DNA damage can last unrepaired for years, changing our view of mutations

Could this fundamental discovery revolutionise fertiliser use in farming?

[Press-News.org] Low levels of a simple sugar -- A new biomarker for severe MS?